Sickle Cell Speaks

GBT is a leader in the research and development of blood disorder treatments. In preparation for the launch of their brand new, breakthrough drug for sickle cell disease, they engaged with RIESTER to develop a campaign that would raise awareness of the disease among the most vulnerable populations.